Emcure Pharmaceuticals Limited — Vildagliptin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Vildagliptin · $984.8K export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #4 Indian exporter of Vildagliptin with $984.8K in export value and 64 verified shipments. Emcure Pharmaceuticals Limited holds a 9.7% market share in Vildagliptin exports across 4 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Vildagliptin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Vildagliptin?
Emcure Pharmaceuticals Limited exports Vildagliptin to 4 countries. The largest destination is CHILE accounting for 92.7% of Emcure Pharmaceuticals Limited's Vildagliptin shipments, followed by MAURITIUS (5.6%) and PERU (1.7%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vildagliptin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EMCURE PHARMA CHILE S.P.A. | CHILE | $556.6K | 27 |
| EMCURE PHARMA CHILE S P A | CHILE | $187.7K | 4 |
| EMCURE CHILE SPA | CHILE | $34.7K | 5 |
| THE MAURITIUS PHARMACY (SEEGOBIN) | MAURITIUS | $31.4K | 14 |
| EMCURE PHARMA PERU SOCIEDAD ANONIMA | PERU | $14.0K | 6 |
| THE MAURITIUS PHARMACY SEEGOBIN | MAURITIUS | $10.3K | 2 |
| SCOTT HEALTH LTD | MAURITIUS | $5.5K | 3 |
| LABORATORIO PHARMA ISA | CHILE | $0 | 2 |
| EMERCHEMIE NB CEYLON LIMITED | SRI LANKA | $0 | 1 |
Emcure Pharmaceuticals Limited supplies Vildagliptin to 9 buyers globally. The largest buyer is EMCURE PHARMA CHILE S.P.A. (CHILE), followed by EMCURE PHARMA CHILE S P A (CHILE) and EMCURE CHILE SPA (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vildagliptin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $7.5M worth of Vildagliptin through 1,149 shipments from 178 suppliers to 87 countries, serving 304 buyers globally. Emcure Pharmaceuticals Limited contributes $984.8K to this total, accounting for 9.7% of India's Vildagliptin exports. Emcure Pharmaceuticals Limited ships Vildagliptin to 4 countries through 9 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Vildagliptin Exports?
Emcure Pharmaceuticals Limited's average Vildagliptin shipment value is $15.4K per consignment, based on 64 shipments totaling $984.8K. The largest destination is CHILE (92.7% of Emcure Pharmaceuticals Limited's Vildagliptin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Vildagliptin Exporters?
Emcure Pharmaceuticals Limited ranks #4 among 178 Indian Vildagliptin exporters with a 9.7% market share. The top 3 exporters are AJANTA PHARMA LIMITED ($1.8M), CADILA PHARMACEUTICALS LIMITED ($1.0M), INTAS PHARMACEUTICALS LIMITED ($996.7K). Emcure Pharmaceuticals Limited processed 64 shipments to 4 destination countries.
What Vildagliptin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS PRODUCTS - ( FINISHED PRODUCT) VILDAGLIPTIN 50 MG TABLET 2X15 (VILDAGLIPTIN TABLETS 50 MG ) | $143.8K | 3 |
| PHARMACEUTICALS PRODUCTS FINIS PRODUCT VILDAGLIPTIN 50 MG TABLET 2X15 VILDAGLIPTIN TABLETS 50 MG | $137.7K | 3 |
| VILDAGLIPTIN 50 MG TABLET 2X15 ( VILDAGLIPTIN TABLETS 50 MG ) | $85.9K | 2 |
| PHARMACEUTICALS PRODUCTS -(FINIS. PRODUCT) - VILDAGLIPTIN 50 MG TABLET 2X15 ( VILDAGLIPTIN TABLETS 50 MG ) | $50.0K | 1 |
| PHARMACEUTICALS PRODUCTS FINIS PRODUCT VILDAGLIPTIN 50 MG TABLET 4X15 VILDAGLIPTIN TABLETS 50 MG | $50.0K | 1 |
| VILDAGLIPTIN 50 MG TABLET 2X15(VILDAGLIPTIN TABLETS 50 MG)B/NO.E16XO25005 M/D.02.2025 E/D.01.2027&E16XO25006 M/D.03.2025 | $46.8K | 1 |
| VILDAGLIPTIN 50MG TABS 2X15(VILDAGLIPTINTABS 50MG)B.NO.E16XO23013 TO E16XO23016MFG.13.12.23, 15.12.23, EXP.30.11.25NOS | $37.0K | 3 |
| VILDAGLIPTIN 50MG TABS 2X15(VILDAGLIPTINTABS 50MG)B.NO.E16XO24001 TO E16XO24003MFG.06.01.24,EXP.31.12.25(39571X2X15T)NOS | $31.1K | 3 |
| VILDAGLIPTIN 50MG TABLET 2X15(VILDAGLIPTIN TABS 50MG)B.NO.E16XO23007 TO E16XO23012 MFG.06.12.23,EXP.30.11.25(29440X2X15) | $29.4K | 1 |
| VILDAGLIPTIN 50MG TABS 2X15(VILDAGLIPTINTAB 50MG)B.NO.E16XO24006 TO E16XO24008MFG.07.02.24EXP.31.01.26(36078X2X15)NOS | $29.2K | 3 |
Emcure Pharmaceuticals Limited exports 41 distinct Vildagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS PRODUCTS - ( FINISHED PRODUCT) VILDAGLIPTIN with 3 shipments worth $143.8K.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Vildagliptin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | CADILA PHARMACEUTICALS LIMITED | $1.0M | 22 | 1 | $46.6K |
| 3 | INTAS PHARMACEUTICALS LIMITED | $996.7K | 53 | 7 | $18.8K |
| 4 | EMCURE PHARMACEUTICALS LIMITED ★ | $984.8K | 64 | 4 | $15.4K |
| 6 | MICRO LABS LIMITED | $494.8K | 15 | 8 | $33.0K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $409.8K | 31 | 5 | $13.2K |
Emcure Pharmaceuticals Limited ranks #4 among 178 Indian Vildagliptin exporters. Average shipment value of $15.4K compared to the market average of $42.0K. The closest competitors by value are CADILA PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Vildagliptin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 165 | 14.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 127 | 11.1% |
| DELHI AIR | 71 | 6.2% |
| NHAVA SHEVA SEA (INNSA1) | 59 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 59 | 5.1% |
| Bombay Air | 57 | 5.0% |
| JNPT/ NHAVA SHEVA SEA | 46 | 4.0% |
| MUNDRA SEA (INMUN1) | 43 | 3.7% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Vildagliptin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Vildagliptin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vildagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vildagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 64 individual customs records matching Emcure Pharmaceuticals Limited exporting Vildagliptin, covering 41 formulations to 4 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 87+ countries, 304+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vildagliptin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Vildagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Vildagliptin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vildagliptin. For current shipment-level data, contact TransData Nexus.